[
    [
        {
            "time": "",
            "original_text": "刘格菘第二！年内四只翻倍基金，他竟独占其三",
            "features": {
                "keywords": [
                    "刘格菘",
                    "翻倍基金",
                    "基金经理"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "基金"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "刘格菘第二！年内四只翻倍基金，他竟独占其三",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "今年以来四只翻倍基金 百亿爆款基金最牛大赚84%",
            "features": {
                "keywords": [
                    "翻倍基金",
                    "百亿基金",
                    "收益"
                ],
                "sentiment_score": 0.95,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "基金"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "今年以来四只翻倍基金 百亿爆款基金最牛大赚84%",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【天风医药】通化东宝：三季度公司业绩加速增长，甘精胰岛素市场开发效果良好",
            "features": {
                "keywords": [
                    "通化东宝",
                    "业绩增长",
                    "甘精胰岛素"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【天风医药】通化东宝：三季度公司业绩加速增长，甘精胰岛素市场开发效果良好",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "【天风医药】康泰生物：三季报业绩基本持平，Q4有望恢复快速增长",
            "features": {
                "keywords": [
                    "康泰生物",
                    "三季报",
                    "Q4增长"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【天风医药】康泰生物：三季报业绩基本持平，Q4有望恢复快速增长",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 4,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "PD-1将成新药投资滑铁卢！还有靶点正重蹈PD-1覆辙，涉15家企业",
            "features": {
                "keywords": [
                    "PD-1",
                    "新药投资",
                    "靶点"
                ],
                "sentiment_score": -0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "PD-1将成新药投资滑铁卢！还有靶点正重蹈PD-1覆辙，涉15家企业",
                "Correlation": 8,
                "Sentiment": 3,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 7,
                "Market_Scope": 9,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "A股公司三季报：超八成企业在盈利 海航控股新晋“亏损王”亏损",
            "features": {
                "keywords": [
                    "三季报",
                    "盈利",
                    "海航控股",
                    "亏损"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "航空",
                    "企业"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "A股公司三季报：超八成企业在盈利 海航控股新晋“亏损王”亏损",
                "Correlation": 7,
                "Sentiment": 4,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 6,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "QFII重仓50强来了！聪明钱转投大周期，23股连续20个季度获QFII坚定持有，股价最高涨6倍",
            "features": {
                "keywords": [
                    "QFII",
                    "重仓股",
                    "大周期",
                    "股价上涨"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "股票"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "QFII重仓50强来了！聪明钱转投大周期，23股连续20个季度获QFII坚定持有，股价最高涨6倍",
                "Correlation": 6,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 5,
                "Market_Scope": 7,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "疫情影響逐漸消退，關注高成長龍頭+細分冠軍——醫藥生物上市公司2020年三季報小結",
            "features": {
                "keywords": [
                    "疫情",
                    "高成长龙头",
                    "细分冠军",
                    "医药生物"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "疫情影響逐漸消退，關注高成長龍頭+細分冠軍——醫藥生物上市公司2020年三季報小結",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        }
    ]
]